REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Sinnex Zrt. (Hungary)

Main Activities: Other Chemical Product and Preparation Manufacturing
Secondary Activities: All Other Miscellaneous Food Manufacturing | General Line Grocery Merchant Wholesalers
Full name: SINNEX Muszaki Fejleszto es Tanacsado Zrt. Profile Updated: October 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

Sinnex is a pharmaceutical company. With a focus on the healthcare industry, Sinnex specializes in the development of oral preparations containing natural active ingredients for the prevention and treatment of influenza and COVID viral infections. The company emphasizes pharmaceutical research and development and claims to be the only company to have successfully developed a natural active ingredient, confirmed by clinical trials, for oral anti-viral preparation.

Headquarters
Hajnal utca 22/D
Szentendre; Pest; Postal Code: 2000

Contact Details: Purchase the Sinnex Zrt. report to view the information.

Website: http://www.sinnex.hu

Basic Information
Total Employees:
Purchase the Sinnex Zrt. report to view the information.
Outstanding Shares:
Purchase the Sinnex Zrt. report to view the information.
Registered Capital:
Purchase the Sinnex Zrt. report to view the information.
Financial Auditors:
Purchase the Sinnex Zrt. report to view the information.
Incorporation Date:
October 09, 2007
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
Subsidiaries
FITOREX Kft.
Company Performance
Financial values in the chart are available after Sinnex Zrt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-8.96%▼
Total operating revenue
-10.28%▼
Operating profit (EBIT)
-59.24%▼
EBITDA
-47.82%▼
Net Profit (Loss) for the Period
18.7%▲
Total assets
2.26%▲
Total equity
4.9%▲
Operating Profit Margin (ROS)
-9.43%▼
Net Profit Margin
5.24%▲
Return on Equity (ROE)
3.44%▲
Debt to Equity Ratio
-6.03%▼
Quick Ratio
-3.63%▼
Cash Ratio
-2.24%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo